Abstract
In June 2020, the new “Regulations on the Supervision and Administration of Cosmetics” (CSAR) was finally issued and published in China. This is the first revision of the “Regulations on Hygiene Supervision of Cosmetics” (CHSR) since its publication in 1989. As the basic and fundamental legislation for cosmetics, CSAR has a far-reaching impact on the whole industry and also reveals new trends in scientific research work. To provide an interpretation of this regulation and help enterprises and researchers better understand the new policies, in this study, the main contents of CSAR and its regulatory system were introduced, and the major changes and background considerations were summarized, especially in the definition and scope of cosmetics, classification and categorization, ingredient management, safety evaluation, efficacy substantiation and technical evaluation work. A brief review of technical progress worldwide and a comparison of regulatory requirements were provided where necessary. Finally, new prospects of cosmetic science in China were discussed. In conclusion, CSAR will initiate a renewed and integrated regulatory system for cosmetics. Advanced concepts of supervision, encouragement of innovation, utilization of technical approaches and emphasis on scientific investigations are reflected in the regulations, which will deeply influence the development of both cosmetic products and new ingredients. With all these new challenges and opportunities, everyone involved should get prepared.
Highlights
In June 2020, the long-waited “Regulations on the Supervision and Administration of Cosmetics”(CSAR) was issued by the State Council of China, and this regulation will be implemented fromSupervision of Cosmetics” (CHSR), which was published in 1989
National Medical Product Administration (NMPA), the administration in charge of drugs, medical devices and cosmetics, which was known as China Food and Drug Administration (CFDA) before
According to CSAR, toothpaste shall be regulated in a similar way to general cosmetics
Summary
In June 2020, the long-waited “Regulations on the Supervision and Administration of Cosmetics”. There are more than 1,800,000 valid cosmetic products in China currently in 2020. New techniques and approaches have appeared, and the concepts of supervision and administration have evolved. CSAR, the very basic and fundamental legislation for cosmetics in China, must adapt to the rapid growth and the new trends of cosmetics nowadays. National Medical Product Administration (NMPA), the administration in charge of drugs, medical devices and cosmetics, which was known as China Food and Drug Administration (CFDA) before. With an overview and discussion of the regulatory system, we can get a better understanding of the new policies in CSAR, as well as the latest research progress and new prospects in cosmetic science in China
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
